blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4346758

EP4346758 - STABLE LIQUID PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.03.2024
Database last updated on 25.09.2024
FormerThe international publication has been made
Status updated on  02.12.2022
Formerunknown
Status updated on  28.06.2022
Most recent event   Tooltip26.07.2024Change: Validation statespublished on 28.08.2024  [2024/35]
26.07.2024Change - extension statespublished on 28.08.2024  [2024/35]
Applicant(s)For all designated states
Cerecin Inc.
44 Cook Street, Suite 100-71
Denver, CO 80206 / US
[2024/15]
Inventor(s)01 / LIU, Aikun Julie
Denver, Colorado 80206 / US
02 / KAASGAARD, Thomas
Denver, Colorado 80206 / US
03 / NAIR C K BALACHANDRAN, Murali
Denver, Colorado 80206 / US
04 / HENDERSON, Samuel T.
Denver, Colorado 80206 / US
05 / BOYD, Benjamin
Parkville, Victoria 3052 / AU
 [2024/15]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2024/15]
Application number, filing date22731926.625.05.2022
[2024/15]
WO2022US30819
Priority number, dateUS202163192826P25.05.2021         Original published format: US 202163192826 P
[2024/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022251288
Date:01.12.2022
Language:EN
[2022/48]
Type: A1 Application with search report 
No.:EP4346758
Date:10.04.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 01.12.2022 takes the place of the publication of the European patent application.
[2024/15]
Search report(s)International search report - published on:EP01.12.2022
ClassificationIPC:A61K9/00, A61K9/107, A61K31/215, A61K31/23, A61P25/28
[2024/15]
CPC:
A61K9/0095 (EP,IL); A61K9/107 (EP,IL,KR); A61K9/1075 (EP,IL,US);
A61K31/215 (EP,IL); A61K31/23 (EP,IL,KR,US); A61K47/10 (KR);
A61K47/12 (KR); A61K47/14 (KR,US); A61K47/24 (KR,US);
A61K47/44 (KR,US); A61K47/46 (US); A61P25/28 (EP,IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/15]
TitleGerman:STABILE FLÜSSIGE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT HOHEM WIRKSTOFFGEHALT AN MITTELKETTIGEN TRIGLYCERIDEN UND ZUGEHÖRIGE VERFAHREN[2024/15]
English:STABLE LIQUID PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO[2024/15]
French:COMPOSITIONS PHARMACEUTIQUES LIQUIDES STABLES AYANT DES CHARGES MÉDICAMENTEUSES ÉLEVÉES DE TRIGLYCÉRIDES À CHAÎNE MOYENNE ET PROCÉDÉS ASSOCIÉS[2024/15]
Entry into regional phase04.12.2023National basic fee paid 
04.12.2023Designation fee(s) paid 
04.12.2023Examination fee paid 
Examination procedure04.12.2023Examination requested  [2024/15]
04.12.2023Date on which the examining division has become responsible
09.07.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
22.03.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO9408610  (SMITHKLINE BEECHAM CORP [US], et al);
 [XYI]WO2020180980  (CERECIN INC [US]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.